Assessment of Insulin Resistance and Dyslipidaemia Among Centrally Obese Adults in Lagos, Nigeria

Read full text Summarise with VIRAT
Authors: O. Omoyele, T. M. Adaja, Y. B. Alabi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Insulin resistance and dyslipidemia represent critical pathophysiological mechanisms underlying metabolicsyndrome and type 2 diabetes mellitus, particularly among obese populations in rapidly urbanizing Africancities. Lagos, Nigeria’s largest metropolis with 17 million inhabitants and 85% urbanization rate, exemplifiesthe epidemiological transition driving obesity-related metabolic disorders. Despite the escalating burden ofobesity in Lagos, limited data exist on the prevalence and determinants of insulin resistance among centrallyobese individuals in this unique urban context, hampering the development of targeted interventions andevidence-based public health policies. This study aimed to determine the prevalence of insulin resistanceand dyslipidemia among centrally obese adults attending the Metabolic Clinic at Lagos University TeachingHospital, and to identify key anthropometric and biochemical predictors of insulin resistance. A hospital-based cross-sectional study was conducted involving 178 centrally obese adults (BMI ≥ 30 kg/m2) and 90non-obese controls recruited through consecutive sampling. Anthropometric measurements including weight,height, body mass index (BMI), waist circumference (WC), hip circumference, and waist-hip ratio (WHR)were obtained using standardized techniques. After overnight fasting, venous blood samples were collected formeasurement of plasma glucose, insulin, and lipid profiles (total cholesterol, triglycerides, HDL-cholesterol,LDL-cholesterol). Insulin resistance was assessed using the Homeostatic Model Assessment of Insulin Resis-tance (HOMA-IR), with HOMA-IR ≥ 2.5 defining insulin resistance. Data were analyzed using Student’st-test, Chi-square test, Pearson’s correlation, and multiple logistic regression, with statistical significance setat p < 0.05. The mean age of centrally obese participants was 48.5 ± 13.1 years, with 51.7% being female.The majority (58.5%) had tertiary education. The median HOMA-IR was significantly higher in the obesegroup (2.67, IQR 2.36) compared to controls (1.16, IQR 0.70, p < 0.001), with an estimated insulin resis-tance prevalence of 55%. Centrally obese participants had significantly higher mean waist circumference(105.9 ± 9.3 vs 79.7 ± 8.3 cm, p < 0.001), BMI (33.9 ± 6.3 vs 24.1 ± 5.7 kg/m2, p < 0.001), plasma insulin(19.41 ± 8.96 vs 4.33 ± 2.43 μU/mL, p < 0.001), triglycerides (1.08 ± 0.50 vs 0.84 ± 0.39 mmol/L, p < 0.001),total cholesterol (5.20 ± 1.33 vs 4.54 ± 0.97 mmol/L, p = 0.044), and lower HDL-cholesterol (1.05 ± 0.37 vs1.19 ± 0.42 mmol/L, p = 0.005). Hypertension prevalence was 41.0% versus 23.3% in controls (p = 0.005,RR=1.76), while hypercholesterolemia was 14.6% versus 5.6% (p = 0.015, RR=2.61). Multivariate logisticregression identified waist circumference as the strongest independent predictor of insulin resistance (AOR2.34 per 10 cm increase, 95% CI: 1.67–3.28, p < 0.001), followed by hypertriglyceridemia (AOR 2.18, 95%CI: 1.12–4.24, p = 0.022) and hypertension (AOR 1.92, 95% CI: 1.08–3.41, p = 0.026). Approximately 68%of centrally obese participants met IDF criteria for metabolic syndrome. This study demonstrates a highburden of insulin resistance (55%) and atherogenic dyslipidemia among centrally obese adults in Lagos, withwaist circumference emerging as the most important predictor. These findings necessitate urgent need for rou-tine waist circumference screening, comprehensive metabolic assessment, and targeted lifestyle interventionsto prevent diabetes and cardiovascular disease in Nigeria’s rapidly urbanizing populations. The clusteringof metabolic abnormalities in over two-thirds of participants highlights the critical importance of address-ing obesity as a serious medical condition requiring comprehensive metabolic management in urban Africansettings.

Fields of Study & Subjects

Diabetes Cardiovascular Risks and Lipoproteins Adipokines Inflammation and Metabolic Diseases Obesity Physical Activity Diet

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
28 March 2026
Language
EN